Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004771434 | SCV005380724 | pathogenic | Joubert syndrome and related disorders | 2024-08-09 | criteria provided, single submitter | clinical testing | Variant summary: TCTN3 c.622dupT (p.Tyr208LeufsX34) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 250126 control chromosomes. To our knowledge, no occurrence of c.622dupT in individuals affected with Joubert Syndrome And Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. |
Fulgent Genetics, |
RCV005040786 | SCV005678471 | likely pathogenic | Orofacial-digital syndrome IV; Joubert syndrome 18 | 2024-03-20 | criteria provided, single submitter | clinical testing |